{"retracted":false,"update":{"timestamp":1420070400000,"doi":"10.1016/j.lrr.2015.04.003","type":"err"},"doi":"10.1016/j.lrr.2014.05.003","journal":"Leukemia Research Reports","publisher":"Elsevier BV","title":"Corrigendum to “Combination therapy with interferon and JAK1-2 inhibitor is feasible. Proof of concept with rapid reduction in JAK2V617F-allele burden in Polycythemia Vera” [Leuk. Res. Rep. 3 (2) (2014) 73–75]"}
